News & Media

Teva Pharma Belgium, part of Teva Pharmaceuticals Ltd, has been developing and manufacturing medicines that improve people's lives for more than a century. We are part of a global leader in generic and innovative medicines with a portfolio of more than 3,600 products in almost every therapeutic area.
Around 200 million people around the world use a Teva medicine every day and are served by one of the largest and most complex supply chains in the pharmaceutical industry.

In addition to our established reputation in generics, we also have significant innovative research and operational activities that support our growing portfolio of innovative and biopharmaceutical products.

Teva Pharma Belgium can rely on this global innovation and production.
Belgian patients count on our innovative, accessible and affordable medicines. In Belgium,
we sell some 530 medicines, intended for numerous treatments (oncology, muscular diseases, heart problems, high blood pressure, high cholesterol, asthma, ...).
In Belgium, our generic and OTC products are distributed by Arega Pharma, also a Belgian company

Teva is committed to a single goal: manufacturing healthcare products and making them available to the greatest possible number of healthcare professionals and patients.
Teva attaches great importance to ethical rules, based on respect and responsibility.
Patients' health is our priority.